JBJohn W. Burns

John W. Burns

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John W. Burns has a total of 166 co-authors. Here are the top co-authors by number of shared publications:

  • David A. Smith

    Department of Psychology, University of Notre Dame, Notre Dame, IN, United States

    9 shared publications
  • Asokumar Buvanendran

    Department of Anesthesiology, Rush University Medical Center, Chicago, Illinois

    8 shared publications
  • Francis J. Keefe

    Department of Psychiatry and Behavioral Science, Duke University Medical Center, Durham, North Carolina

    7 shared publications
  • Laura S. Porter

    Department of Psychiatry and Behavioral Science, Duke University Medical Center, Durham, North Carolina

    7 shared publications
  • Stephen Bruehl

    Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, USA

    7 shared publications
  • Anne Marie Fras

    Department of Psychiatry and Behavioral Science, Duke University Medical Center, Durham, North Carolina

    6 shared publications

Latest Publications

  • Mechanisms of behavioral activation, cognitive therapy, and mindfulness meditation for chronic pain: a test of specific vs shared mechanism models in a randomized clinical trial

    by Melissa A. Day, L. Charles Ward, Jeffrey Borckardt, John Burns, Andrea K. Newman, Dawn M. Ehde, Joy F. Chan, David Reed, Janna L. Friedly, Beverly E. Thorn, et al.

    This study tested hypotheses regarding the mechanisms of 3 psychological chronic pain treatments: behavioral activation, cognitive therapy, and mindfulness meditation. The aim was to evaluate the degree to which improvement in the primary outcome (pain interference) was accounted for by preceding changes in cognitive content (pain catastrophizing), cognitive process (mindful nonjudgment), and/or behavior (activity level) during treatment (Primary Aim) and after treatment (Secondary Aim). A total of 302 adults with chronic low back pain were enrolled in a 3-arm parallel randomized clinical trial and completed twice daily ecological momentary assessments of outcome and hypothesized mechanism variables. Participants also wore an activity monitor daily during and after treatment. Slopes were calculated for 4 phases (early treatment, late treatment, early post-treatment, late post-treatment), and analyses of variance were conducted. Structural equation modeling evaluated potential cross-lagged effects. The analyses of variance results showed significant improvement in pain interference, pain catastrophizing, and nonjudgment, but not activity level, with no between treatment differences. The structural equation modeling analyses testing the potential mechanism role of pain catastrophizing and nonjudgment during treatment and after treatment mostly found nonsignificant cross-lagged effects, although changes in outcome and mechanism were significantly correlated at nearly all time periods. Taken together, the strongest support was found for a Shared Mechanisms Model to explain how 3 theoretically unique treatments exert change both during and after treatment. The findings are among the first to delineate the potential mechanisms underlying the variability in post-treatment trajectories of maintenance vs relapse after psychological chronic pain treatment.


  • Modeling Relationships Among Pain and Function in Individuals With Knee Osteoarthritis in the A2CPS Cohort

    by Giovanni Berardi, Laura Frey Law, Robert McCarthy, John Burns, Carol Vance, Dana L. Dailey, Michael Charters, Andrew Urquhart, Elizabeth Dailey, Tor D. Wager, et al.

    Objectives: Individuals with knee osteoarthritis (KOA) experience both pain and functional limitations that negatively impact quality of life and contribute to years lived with disability. Movement-evoked pain (MEP) is thought to act as a barrier to participation in daily activities, resulting in reduced function. The aim of this study was to examine the relationships between knee-specific measures of self-reported pain interference, fear avoidance, and performance-based MEP and their associations with physical function among individuals with KOA seeking joint arthroplasty. Methods: Using baseline data from the Acute to Chronic Pain Signatures Consortium (training data: release 1.0.0, n=603; validation data: release 2.0.0, n=441), this cross-sectional study used structural equation modeling to examine associations among self-reported pain, movement-evoked pain, and physical function. We further evaluated whether these relationships differed by task specificity and biological sex. Results: Greater self-reported knee pain interference and higher fear avoidance were associated with poorer physical function ( β =−0.83, P β =−0.11, P =0.072) and was weakly associated with self-report knee pain interference and fear avoidance ( β =0.36, P <0.001). These patterns were consistent in a validation dataset. Discussion: These findings suggest knee-specific self-report measures (pain, pain interference, and fear avoidance) and performance-based MEP are unique constructs. Self-report measures of knee pain interference and fear avoidance were more strongly related to the functional limitations in KOA compared with to performance-based MEP.


  • Open Access

    At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial (Preprint)

    by Helen J Burgess, Allie A Rodgers, Kiley A McNeil, Jackson Mott, Agnes Fejer, Tori Dereski, Muneer Rizvydeen, Kimberly T Sibille, Hyungjin Myra Kim, Cherie Cofield, et al.

    BACKGROUND Fibromyalgia, the quintessential nociplastic pain condition, affects more than 20 million Americans and results in significant disability, lost productivity, and poor quality of life, with profound individual and societal cost. As pharmacological treatment approaches offer only modest benefits and result in a high rate of discontinuation due to adverse effects, nonpharmacological interventions such as physical therapy, exercise, and cognitive behavioral therapy are recommended. However, cost and access to these treatments can create barriers to care, and engagement can be problematic. Morning bright light treatment is a promising option for improving fibromyalgia symptoms, with early studies indicating clinically meaningful improvements in fibromyalgia symptoms. OBJECTIVE This study aims to prospectively examine the potential benefits and active elements of morning bright light treatment and sleep timing stabilization for individuals with fibromyalgia in the largest randomized controlled trial to date. METHODS We will recruit 390 adults who meet diagnostic criteria for fibromyalgia and report at least mild symptoms. Participants will be randomized to one of three groups: 4 weeks of morning bright light treatment (1 hour per day, using a commercially available Re-timer device), 4 weeks of sleep timing stabilization alone (a component of morning bright light treatment, some benefit anticipated), or 4 weeks of treatment as usual, with equivalent study contact. Patient-reported outcomes of function and pain will be assessed before and after treatment, with mood, sleep quality, and morningness-eveningness examined as potential mediators of treatment effects. Social determinants of health risk will be examined as a potential moderator influencing baseline symptoms, treatment engagement, and treatment response. RESULTS Data collection began in September 2024 and is projected to end in March 2029. CONCLUSIONS Morning bright light treatment is well-positioned to be an effective nonpharmacological treatment for fibromyalgia with minimal side effects. The study findings will provide important insights relevant to the development of morning bright light treatment as an accessible treatment for chronic nociplastic pain. CLINICALTRIAL ClinicalTrials.gov NCT06567886; https://clinicaltrials.gov/study/NCT06567886 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/75060

  • Open Access

    At Home Morning Bright Light Treatment for Chronic Nociplastic Pain: A Protocol for A Randomized Clinical Trial (Preprint)

    by Helen J. Burgess, Allie A. Rodgers, Kiley A. McNeil, Jackson Mott, Agnes Fejer, Tori Dereski, Muneer Rizvydeen, Kimberly T. Sibille, Hyungjin Myra Kim, Cherie Cofield, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).


  • Open Access

    Comparative main effects, mediators, and moderators of cognitive behavioral therapy, acceptance and commitment therapy, and emotional awareness and expression therapy for chronic spinal pain: Randomized controlled trial rationale and protocol

    by John W. Burns, Mark A. Lumley, Kevin E. Vowles, Mark P. Jensen, Melissa A. Day, Howard Schubiner, Emma Jaszczak, Britney Abro, Sarah H. Addicks, Michael J. Bordieri, et al.


  • Treatment mechanism and outcome decoupling effects in cognitive therapy, mindfulness-based stress reduction, and behavior therapy for chronic pain

    by James Gerhart, John W. Burns, Beverly Thorn, Mark Jensen, James Carmody, Francis Keefe

    Findings suggest that cognitive therapy (CT), mindfulness-based stress reduction (MBSR), and behavior therapy (BT) for chronic pain produce improvements through changes in putative mechanisms. Evidence supporting this notion is largely based on findings showing significant associations between treatment mechanism variables and outcomes. An alternative view is that treatments may work by reducing or decoupling the impact of changes in mechanism variables on changes in outcomes. We examined the degree to which relationships between previous changes in potential treatment mechanisms and subsequent changes in outcomes changed as treatment progressed and vice versa. Cognitive therapy, MBSR, BT, and treatment as usual (TAU) were compared in people with chronic low back pain (N = 521). Eight individual sessions were administered with weekly assessments of putative treatment mechanisms and outcomes. Lagged analyses revealed mechanism × session number interactions and outcome × session number interactions, such that associations between mechanism and outcome variables were strong and significant in the first third of treatment, but weakened over time and became nonsignificant by the last third of treatment. These effects were similar across treatment conditions but did not emerge among people undergoing TAU. Results suggest that during the course of CT, MBSR, and BT, the links between changes in treatment mechanism variables became decoupled from subsequent changes in outcomes and vice versa. Thus, starting by midtreatment and continuing into late treatment, participants may have learned through participation in the treatments that episodes of maladaptive pain-related thoughts and/or spikes in pain need not have detrimental consequences on their subsequent experience.


  • Concurrent and lagged associations among pain medication use, pain, and negative affect: a daily diary study of people with chronic low back pain

    by John W. Burns, James Gerhart, David A. Smith, Laura Porter, Bonny Rye, Francis Keefe

    People with chronic pain often attempt to manage pain and concurrent emotional distress with analgesic substances. Habitual use of such substances—even when not opioid-based—can pose side effect risks. A negative reinforcement model has been proposed whereby relief of pain and emotional distress following medication consumption increases the likelihood that the experience of elevated pain and distress will spur further medication use. People with chronic low back pain (N = 105) completed electronic diary assessments 5 times/day for 14 consecutive days. Lagged and cross-lagged analyses focused on links between time 1 pain and negative affect (NA) and time 2 analgesic medication use and vice versa. Sex differences were also explored. Primary results were as follows: (1) participants on average reported taking analgesic medication during 41.3% of the 3-hour reporting epochs (29 times over 14 days); (2) time 1 within-person increases in pain and NA predicted time 2 increases in the likelihood of ingesting analgesic medications; (3) time 1 within-person increases in medication use predicted time 2 decreases in pain and NA; and (4) lagged associations between time 1 pain/NA and time 2 medication use were strongest among women. Findings suggest that the use of analgesic medications for many people with chronic pain occurs frequently throughout the day. Results support the validity of a negative reinforcement model where pain and distress lead to pain medication use, which in turn leads to relief from pain and distress.


  • Cognitive therapy, mindfulness-based stress reduction, and behavior therapy for the treatment of chronic pain: randomized controlled trial

    by John W. Burns, Mark P. Jensen, Beverly E. Thorn, Teresa A. Lillis, James Carmody, Andrea K. Newman, Francis Keefe

    Trials of cognitive therapy (CT), mindfulness-based stress reduction (MBSR), and behavior therapy (BT) suggest that all 3 treatments produce reductions in pain and improvements in physical function, mood, and sleep disturbance in people with chronic pain conditions. Fewer studies have compared the relative efficacies of these treatments. In this randomized controlled study, we compared CT, MBSR, BT, and treatment as usual (TAU) in a sample of people with chronic low back pain (N = 521). Eight individual sessions were administered with weekly assessments of outcomes. Consistent with the prior work, we found that CT, MBSR, and BT produced similar pretreatment to posttreatment effects on all outcomes and revealed similar levels of maintenance of treatment gains at 6-month follow-up. All 3 active treatments produced greater improvements than TAU. Weekly assessments allowed us to assess rates of change; ie, how quickly a given treatment produced significant differences, compared with TAU, on a given outcome. The 3 treatments differed significantly from TAU on average by session 6, and this rate of treatment effect was consistent across all treatments. Results suggest the possibility that the specific techniques included in CT, MBSR, and BT may be less important for producing benefits than people participating in any techniques rooted in these evidence-based psychosocial treatments for chronic pain.


  • Open Access

    Psychosocial Correlates of Objective, Performance-Based, and Patient-Reported Physical Function Among Patients with Heterogeneous Chronic Pain

    by Jonathan Greenberg, Ryan A Mace, Paula J Popok, Ronald J Kulich, Kushang V Patel, John W Burns, Tamara J Somers, Francis J. Keefe, Michael E Schatman, Ana-Maria Vrancenanu

    Background: Improving all aspects of physical function is an important goal of chronic pain management. Few studies follow recent guidelines to comprehensively assess physical function via patient-reported, performance-based, and objective/ambulatory measures. Purpose: To test 1) the interrelation between the 3 types of physical function measurement and 2) the association between psychosocial factors and each type of physical function measurement. Methods: Patients with chronic pain (N=79) completed measures of: 1) physical function (patient-reported disability; performance-based 6-minute walk-test; objective accelerometer step count); 2) pain and non-adaptive coping (pain during rest and activity, pain-catastrophizing, kinesiophobia); 3) adaptive coping (mindfulness, general coping, pain-resilience); and 4) social-emotional dysfunction (anxiety, depression, social isolation and emotional support). First, we tested the interrelation among the 3 aspects of physical function. Second, we used structural equation modeling to test associations between psychosocial factors (pain and non-adaptive coping, adaptive coping, and social-emotional dysfunction) and each measurement of physical function. Results: Performance-based and objective physical function were significantly interrelated (r=0.48, p< 0.001) but did not correlate with patient-reported disability. Pain and non-adaptive coping (β=0.68, p< 0.001), adaptive coping (β=− 0.65, p< 0.001) and social-emotional dysfunction (β=0.65, p< 0.001) were associated with patient-reported disability but not to performance-based or objective physical function (ps> 0.1). Conclusion: Results suggest that patient-reported physical function may provide limited information about patients’ physical capacity or ambulatory activity. While pain and non-adaptive reactions to it, adaptive coping, and social-emotional dysfunction may potentially improve patient-reported physical function, additional targets may be needed to improve functional capacity and ambulatory activity. Trial Registration: ClinicalTrials.gov NCT03412916.